Literature DB >> 11378836

Association study of the 5-HT(2A) receptor gene polymorphism, T102C and essential hypertension.

D Liolitsa1, J F Powell, M Prince, S Lovestone.   

Abstract

BACKGROUND: Serotonin dysfunction has been implicated in hypertension due to its ability to induce vasoconstriction via stimulation of 5-HT(2) receptors and due to the antihypertensive effect of ketanserin, an antagonist at the 5-HT(2A) receptor subtype, expressed both on arteries and the brain. The silent T102C polymorphism in the 5-HT(2A) gene is in absolute linkage disequilibrium with a polymorphism in the promoter and may contribute to genetic predisposition possibly by modifying the transcription of the gene.
OBJECTIVE: To examine the genetic contribution of the T102C 5-HT(2A)polymorphism in essential hypertension in a case-control sample of UK residents.
DESIGN: The hypertensive group consisted of 342 subjects over 75 years and the community-based control group consisted of 319 subjects. Subjects were genotyped for the T102C polymorphism by Mspl restriction enzyme digestion following PCR amplification.
RESULTS: Sex-specific association analysis revealed significant differences between hypertensive and normotensive subjects in the genotypes distribution (P = 0.016) and allelic frequencies (P = 0.007) in the female group. The direction of significance was increased frequency of the 102-C allele in the hypertensive subjects. There were no association between haplotype and age or body mass index, which suggest that the effect of the T102C variant is not influenced by these variables.
CONCLUSION: This data indicates that the T102C polymorphism in the 5-HT(2A) gene might be an independent risk factor for increased blood pressure in female individuals with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378836     DOI: 10.1038/sj.jhh.1001177

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  9 in total

1.  Gender specific association of CYP2C9*3 with hyperlipidaemia in Chinese.

Authors:  Chen-Hui Luo; An Wang; Rong-Hua Zhu; Wei-Xia Zhang; Wei Mo; Bang-Ning Yu; Guo-Lin Chen; Dong-Sheng Ou-Yang; Xiao-Hong Duan; A M Abd El-Aty; Hong-Hao Zhou
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

2.  Association of the 5-HT2A receptor gene polymorphism 102T/C with ischemic stroke.

Authors:  Ole F Olesen; Bente Bennike; Henrik Dam; Erling Mellerup
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Genetic associations with hypertension: meta-analyses of six candidate genetic variants.

Authors:  Cheng Zhang; Lingyan Wang; Qi Liao; Lina Zhang; Leiting Xu; Cheng Chen; Huadan Ye; Xuting Xu; Meng Ye; Shiwei Duan
Journal:  Genet Test Mol Biomarkers       Date:  2013-07-16

4.  Prostate cancer in elderly Croatian men: 5-HT genetic polymorphisms and the influence of androgen deprivation therapy on osteopenia--a pilot study.

Authors:  Daria Pašalić; Paulina Pauković; Selma Cvijetić; Alica Pizent; Jasna Jurasović; Sanja Milković-Kraus; Slavica Dodig; Dorotea Mück-Šeler; Maja Mustapić; Nela Pivac; Mladen Pavlović
Journal:  Genet Test Mol Biomarkers       Date:  2012-03-15

5.  NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in Japanese children.

Authors:  Kyoko Maruyama; Kazumoto Iijima; Masahiro Ikeda; Akiko Kitamura; Hiroyasu Tsukaguchi; Kunihiko Yoshiya; Sakurako Hoshii; Naohiro Wada; Osamu Uemura; Kenichi Satomura; Masataka Honda; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2003-04-05       Impact factor: 3.714

6.  Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice.

Authors:  Scott P Heximer; Russell H Knutsen; Xiaoguang Sun; Kevin M Kaltenbronn; Man-Hee Rhee; Ning Peng; Antonio Oliveira-dos-Santos; Josef M Penninger; Anthony J Muslin; Thomas H Steinberg; J Michael Wyss; Robert P Mecham; Kendall J Blumer
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

7.  Serotonin Receptor 2A (HTR2A) Gene Polymorphisms Are Associated with Blood Pressure, Central Adiposity, and the Metabolic Syndrome.

Authors:  Indrani Halder; Matthew F Muldoon; Robert E Ferrell; Stephen B Manuck
Journal:  Metab Syndr Relat Disord       Date:  2007-12       Impact factor: 1.894

8.  Serotonin 5-HT2A receptor activity mediates adipocyte differentiation through control of adipogenic gene expression.

Authors:  Bangning Yu; Diana M Battaglia; Timothy P Foster; Charles D Nichols
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

9.  Association between serotonin 2A receptor (HTR2A) genetic variations and risk of hypertension in a community-based cohort study.

Authors:  Jung Ran Choi; Minhee Jeon; Sang Baek Koh
Journal:  BMC Med Genet       Date:  2020-01-06       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.